Search

Author/Creator Mohr, Isabelle

1. Optimized Trientine-dihydrochloride Therapy in Pediatric Patients With Wilson Disease: Is Weight-based Dosing Justified?. Issue 1 (January 2021)

Authors:
Mayr, Toni; Ferenci, Peter; Weiler, Markus; Fichtner, Alexander; Mehrabi, Arianeb; Hoffmann, Georg Friedrich; Mohr, Isabelle; Pfeiffenberger, Jan; Weiss, Karl Heinz; Teufel-Schäfer, Ulrike
Journal:
Journal of pediatric gastroenterology and nutrition
Issue:
Volume 72:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. (December 2022)

Authors:
Schilsky, Michael L; Czlonkowska, Anna; Zuin, Massimo; Cassiman, David; Twardowschy, Carlos; Poujois, Aurelia; Gondim, Francisco de Assis A; Denk, Gerald; Cury, Rubens G; Ott, Peter; Moore, Joanna; Ala, Aftab; D'Inca, Renata; Couchonnal-Bedoya, Eduardo; D'Hollander, Koenraad; Dubois, Nicolas; Kam...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 12(2022)
Page Start:
1092
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl. Issue 2 (12th November 2022)

Authors:
Mohr, Isabelle; Bourhis, Hélène; Woimant, France; Obadia, Mickael Alexandre; Morgil, Müzeyyen; Morvan, Erwan; Merle, Uta; Denk, Gerald; Poujois, Aurelia; Weiss, Karl Heinz
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 38:Issue 2(2023)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗